<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on November 18, 2026 at 1:27 PM by All in One SEO v5.0.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Wed, 18 Nov 2026 13:23:50 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/photocure-and-clinigen-expand-hexvix-access-globally/]]></guid>
			<link><![CDATA[https://cgxpwire.com/photocure-and-clinigen-expand-hexvix-access-globally/]]></link>
			<title>Photocure and Clinigen Expand Hexvix Access Globally</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 13:23:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/genomics-and-vertex-extend-drug-discovery-collaboration/]]></guid>
			<link><![CDATA[https://cgxpwire.com/genomics-and-vertex-extend-drug-discovery-collaboration/]]></link>
			<title>Genomics and Vertex Extend Drug Discovery Collaboration</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 13:14:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/fda-fast-track-designation-for-elticertinib-in-nsclc/]]></guid>
			<link><![CDATA[https://cgxpwire.com/fda-fast-track-designation-for-elticertinib-in-nsclc/]]></link>
			<title>FDA Fast Track Designation for Elticertinib in NSCLC</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 12:48:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/beren-wins-fda-approval-for-lembaz-in-rare-npc-disease/]]></guid>
			<link><![CDATA[https://cgxpwire.com/beren-wins-fda-approval-for-lembaz-in-rare-npc-disease/]]></link>
			<title>Beren Wins FDA Approval for LEMBAZ in Rare NPC Disease</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 12:46:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/servier-reports-sustained-voranigo-benefit-in-idh-glioma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/servier-reports-sustained-voranigo-benefit-in-idh-glioma/]]></link>
			<title>Servier Reports Sustained VORANIGO Benefit in IDH Glioma</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 12:21:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/curegene-reveals-cg-0416-obesity-research-findings/]]></guid>
			<link><![CDATA[https://cgxpwire.com/curegene-reveals-cg-0416-obesity-research-findings/]]></link>
			<title>CureGene Reveals CG-0416 Obesity Research Findings</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 11:46:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/quralis-wins-fda-ind-clearance-for-als-drug-qrl-201/]]></guid>
			<link><![CDATA[https://cgxpwire.com/quralis-wins-fda-ind-clearance-for-als-drug-qrl-201/]]></link>
			<title>QurAlis Wins FDA IND Clearance for ALS Drug QRL-201</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 11:24:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/tivicay-and-dovato-gain-positive-eu-opinion-for-children/]]></guid>
			<link><![CDATA[https://cgxpwire.com/tivicay-and-dovato-gain-positive-eu-opinion-for-children/]]></link>
			<title>Tivicay and Dovato Gain Positive EU Opinion for Children</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 11:01:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/igi-submits-isb-2301-ind-for-solid-tumor-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/igi-submits-isb-2301-ind-for-solid-tumor-therapy/]]></link>
			<title>IGI Submits ISB 2301 IND for Solid Tumor Therapy</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 05:23:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/labcorp-expands-clinical-trial-operations-across-brazil/]]></guid>
			<link><![CDATA[https://cgxpwire.com/labcorp-expands-clinical-trial-operations-across-brazil/]]></link>
			<title>Labcorp Expands Clinical Trial Operations Across Brazil</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 05:06:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/inhibrx-reports-updated-ozekibart-results-in-ewing-sarcoma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/inhibrx-reports-updated-ozekibart-results-in-ewing-sarcoma/]]></link>
			<title>Inhibrx Reports Updated Ozekibart Results in Ewing Sarcoma</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:46:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/roche-wins-fda-approval-for-gazyva-in-kidney-disease/]]></guid>
			<link><![CDATA[https://cgxpwire.com/roche-wins-fda-approval-for-gazyva-in-kidney-disease/]]></link>
			<title>Roche Wins FDA Approval for Gazyva in Kidney Disease</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:37:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/karyopharm-fda-accepts-xpovio-myelofibrosis-drug-filing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/karyopharm-fda-accepts-xpovio-myelofibrosis-drug-filing/]]></link>
			<title>Karyopharm FDA Accepts XPOVIO Myelofibrosis Drug Filing</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:34:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/sine-health-wins-fda-clearance-for-tremor-monitoring-app/]]></guid>
			<link><![CDATA[https://cgxpwire.com/sine-health-wins-fda-clearance-for-tremor-monitoring-app/]]></link>
			<title>Sine Health Wins FDA Clearance for Tremor Monitoring App</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:30:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/werfen-wins-fda-clearance-for-rotem-sigma-trauma-test/]]></guid>
			<link><![CDATA[https://cgxpwire.com/werfen-wins-fda-clearance-for-rotem-sigma-trauma-test/]]></link>
			<title>Werfen Wins FDA Clearance for ROTEM sigma Trauma Test</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:25:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medtronic-wins-fda-clearance-for-hugo-robotic-surgery/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medtronic-wins-fda-clearance-for-hugo-robotic-surgery/]]></link>
			<title>Medtronic Wins FDA Clearance for Hugo Robotic Surgery</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:19:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/roche-wins-fda-approval-for-new-wilserdly-breast-cancer-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/roche-wins-fda-approval-for-new-wilserdly-breast-cancer-drug/]]></link>
			<title>Roche Wins FDA Approval for New Wilserdly Breast Cancer Drug</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:16:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/us-worldmeds-to-present-final-tecelra-trial-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/us-worldmeds-to-present-final-tecelra-trial-results/]]></link>
			<title>US WorldMeds to Present Final TECELRA Trial Results</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:11:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/minimed-wins-fda-clearance-for-seven-day-tubeless-pump/]]></guid>
			<link><![CDATA[https://cgxpwire.com/minimed-wins-fda-clearance-for-seven-day-tubeless-pump/]]></link>
			<title>MiniMed Wins FDA Clearance for Seven-Day Tubeless Pump</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 04:02:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/novartis-wins-fda-approval-for-cosentyx-in-pmr/]]></guid>
			<link><![CDATA[https://cgxpwire.com/novartis-wins-fda-approval-for-cosentyx-in-pmr/]]></link>
			<title>Novartis Wins FDA Approval for Cosentyx in PMR</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 03:58:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/viatris-completes-1-65b-pacira-biosciences-acquisition/]]></guid>
			<link><![CDATA[https://cgxpwire.com/viatris-completes-1-65b-pacira-biosciences-acquisition/]]></link>
			<title>Viatris Completes $1.65B Pacira BioSciences Acquisition</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 03:54:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/regeneron-wins-eu-approval-for-flexible-libtayo-dosing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/regeneron-wins-eu-approval-for-flexible-libtayo-dosing/]]></link>
			<title>Regeneron Wins EU Approval for Flexible Libtayo Dosing</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 03:46:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/akeso-ivonescimab-snda-accepted-for-biliary-tract-cancer/]]></guid>
			<link><![CDATA[https://cgxpwire.com/akeso-ivonescimab-snda-accepted-for-biliary-tract-cancer/]]></link>
			<title>Akeso Ivonescimab sNDA Accepted for Biliary Tract Cancer</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 12:59:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/uniquity-bio-reports-positive-phase-2-results-for-solrikitug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/uniquity-bio-reports-positive-phase-2-results-for-solrikitug/]]></link>
			<title>Uniquity Bio Reports Positive Phase 2 Results for Solrikitug</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 12:39:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/promis-licenses-txp1-technology-to-advance-brain-drug-delivery/]]></guid>
			<link><![CDATA[https://cgxpwire.com/promis-licenses-txp1-technology-to-advance-brain-drug-delivery/]]></link>
			<title>ProMIS Licenses TXP1 Technology to Advance Brain Drug Delivery</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 12:11:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/akesos-gumokimab-wins-nmpa-approval-for-ankylosing-spondylitis/]]></guid>
			<link><![CDATA[https://cgxpwire.com/akesos-gumokimab-wins-nmpa-approval-for-ankylosing-spondylitis/]]></link>
			<title>Akeso’s Gumokimab Wins NMPA Approval for Ankylosing Spondylitis</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 11:44:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/ascletis-advances-once-weekly-oral-obesity-drug-to-fda/]]></guid>
			<link><![CDATA[https://cgxpwire.com/ascletis-advances-once-weekly-oral-obesity-drug-to-fda/]]></link>
			<title>Ascletis Advances Once-Weekly Oral Obesity Drug to FDA</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 10:48:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medicept-explains-fdas-new-inspection-approach-for-medtech/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medicept-explains-fdas-new-inspection-approach-for-medtech/]]></link>
			<title>Medicept Explains FDA&#8217;s New Inspection Approach for Medtech</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 05:08:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/viking-therapeutics-reports-new-vk2735-obesity-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/viking-therapeutics-reports-new-vk2735-obesity-data/]]></link>
			<title>Viking Therapeutics Reports New VK2735 Obesity Data</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 05:03:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/fortvita-advances-zybrivo-for-first-line-lung-cancer-treatment/]]></guid>
			<link><![CDATA[https://cgxpwire.com/fortvita-advances-zybrivo-for-first-line-lung-cancer-treatment/]]></link>
			<title>Fortvita Advances Zybrivo for First-Line Lung Cancer Treatment</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 05:01:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/roche-and-nordic-bioscience-advance-endotrophin-assay/]]></guid>
			<link><![CDATA[https://cgxpwire.com/roche-and-nordic-bioscience-advance-endotrophin-assay/]]></link>
			<title>Roche and Nordic Bioscience Advance Endotrophin Assay</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:56:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biolinerx-and-hemispherian-present-new-glix1-data-at-sno-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biolinerx-and-hemispherian-present-new-glix1-data-at-sno-2026/]]></link>
			<title>BioLineRx and Hemispherian Present New GLIX1 Data at SNO 2026</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:50:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/dariohealth-presents-biometric-based-healthcare-roi-model/]]></guid>
			<link><![CDATA[https://cgxpwire.com/dariohealth-presents-biometric-based-healthcare-roi-model/]]></link>
			<title>DarioHealth Presents Biometric-Based Healthcare ROI Model</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:46:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/protego-reports-new-prot-001-data-in-al-amyloidosis/]]></guid>
			<link><![CDATA[https://cgxpwire.com/protego-reports-new-prot-001-data-in-al-amyloidosis/]]></link>
			<title>Protego Reports New PROT-001 Data in AL Amyloidosis</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:39:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/nuvation-bio-reports-long-term-safusidenib-data-in-glioma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/nuvation-bio-reports-long-term-safusidenib-data-in-glioma/]]></link>
			<title>Nuvation Bio Reports Long-Term Safusidenib Data in Glioma</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:31:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/palatin-advances-selective-peptide-candidates-for-obesity/]]></guid>
			<link><![CDATA[https://cgxpwire.com/palatin-advances-selective-peptide-candidates-for-obesity/]]></link>
			<title>Palatin Advances Selective Peptide Candidates for Obesity</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:31:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/elsevier-advances-clinical-decision-support-with-ai/]]></guid>
			<link><![CDATA[https://cgxpwire.com/elsevier-advances-clinical-decision-support-with-ai/]]></link>
			<title>Elsevier Advances Clinical Decision Support With AI</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:25:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/vector-prepares-major-peptide-medical-development/]]></guid>
			<link><![CDATA[https://cgxpwire.com/vector-prepares-major-peptide-medical-development/]]></link>
			<title>Vector Prepares Major Peptide Medical Development</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:24:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/delonix-advances-omv-vaccine-research-against-k-pneumoniae/]]></guid>
			<link><![CDATA[https://cgxpwire.com/delonix-advances-omv-vaccine-research-against-k-pneumoniae/]]></link>
			<title>Delonix Advances OMV Vaccine Research Against K. pneumoniae</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:18:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/eocene-advances-targeted-aramchol-delivery-for-cancer/]]></guid>
			<link><![CDATA[https://cgxpwire.com/eocene-advances-targeted-aramchol-delivery-for-cancer/]]></link>
			<title>Eocene Advances Targeted Aramchol Delivery for Cancer</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 04:17:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/caris-advances-precision-oncology-through-rna-sequencing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/caris-advances-precision-oncology-through-rna-sequencing/]]></link>
			<title>Caris Advances Precision Oncology Through RNA Sequencing</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 03:59:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/ascletis-advances-oral-and-injectable-obesity-drug-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/ascletis-advances-oral-and-injectable-obesity-drug-research/]]></link>
			<title>Ascletis Advances Oral and Injectable Obesity Drug Research</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 03:54:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/ventric-health-and-stellus-rx-partner-on-heart-failure-care/]]></guid>
			<link><![CDATA[https://cgxpwire.com/ventric-health-and-stellus-rx-partner-on-heart-failure-care/]]></link>
			<title>Ventric Health and Stellus Rx Partner on Heart Failure Care</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:42:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/novo-reports-cagrisema-weight-loss-and-function-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/novo-reports-cagrisema-weight-loss-and-function-results/]]></link>
			<title>Novo Reports CagriSema Weight Loss and Function Results</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:34:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/molecular-designs-wins-fda-clearance-for-respiratory-test/]]></guid>
			<link><![CDATA[https://cgxpwire.com/molecular-designs-wins-fda-clearance-for-respiratory-test/]]></link>
			<title>Molecular Designs Wins FDA Clearance for Respiratory Test</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:30:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/dana-farber-adds-n6-iconpcr-to-low-input-cfdna-sequencing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/dana-farber-adds-n6-iconpcr-to-low-input-cfdna-sequencing/]]></link>
			<title>Dana-Farber Adds n6 iconPCR to Low-Input cfDNA Sequencing</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:26:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/sino-biological-launches-4rise-for-ai-drug-discovery/]]></guid>
			<link><![CDATA[https://cgxpwire.com/sino-biological-launches-4rise-for-ai-drug-discovery/]]></link>
			<title>Sino Biological Launches 4RISE for AI Drug Discovery</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:15:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/servier-reports-four-year-ojemda-data-in-childhood-glioma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/servier-reports-four-year-ojemda-data-in-childhood-glioma/]]></link>
			<title>Servier Reports Four-Year OJEMDA Data in Childhood Glioma</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:09:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/lilly-presents-new-obesity-drug-data-at-obesityweek-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/lilly-presents-new-obesity-drug-data-at-obesityweek-2026/]]></link>
			<title>Lilly Presents New Obesity Drug Data at ObesityWeek 2026</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:07:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/novo-reports-cagrisema-weight-loss-data-at-lower-doses/]]></guid>
			<link><![CDATA[https://cgxpwire.com/novo-reports-cagrisema-weight-loss-data-at-lower-doses/]]></link>
			<title>Novo Reports CagriSema Weight Loss Data at Lower Doses</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 04:04:46 +0000]]></pubDate>
		</item>
				</channel>
</rss>
